The survival time of endometrial cancer is generally related to the severity of the disease and the physical condition of the individual, and the survival rate of five years is relatively high if the disease is actively treated in the early stage. 1. Early stage: The tumor is usually small in the early stage of the disease, and if there is no metastasis, it can be treated by surgical resection, and the survival rate of five years is still relatively high. 2. Intermediate stage: chemotherapy can be used to reduce local symptoms and slow down the spread of cancer cells, thus prolonging the life of patients. However, chemotherapy has certain side effects, which will cause damage to normal cells, and the five-year survival rate is generally not high. 3. Late stage: The spread of cancer cells in late stage, especially if the metastatic scope is relatively large, is very threatening to the patient’s life, so the five-year survival rate is generally shorter. Therefore, endometrial cancer is very dangerous and patients are advised to seek treatment actively to avoid jeopardizing their lives and health.